REGIONAL MEETING



General Information

Next Meetings

Date:     Friday 23 February 2024

Host:     WA PIC

Venue:  Online

Time:     WA    8:00am - 1.00pm
              QLD 10:00am - 3:00pm
              NSW/VIC 11:00am - 4:00pm
              NZ 1:00pm - 6:00pm


Date:     Friday 23 August 2024

Host:     QLD PIC

Venue:  QLD Children's Hospital

Time:     9:30am - 3.00pm (AEST)



Program - 23 February

AEDTAWSTTopic/ActivitySpeaker
11:008:00Acknowledgement of country and welcome by chair
11:058:05TAPNA PresidentDr Adam Pomerleau
11:108:10Fever Pitch
A case of DNP ingestion with rapid deterioration.
Dr Sarah Buller,
Auckland City Hospital
11:308:30Tiny Patient, Big Risk: Local anaesthetic systemic toxicity.
A discussion of local anaesthetic use and current regulations.
Dr Bash Jagarlamudi
Prince of Wales Hospital
11:508:50Arrested Development.
Propanolol ingestion with OHCA and ECMO.
Dr Earl Butler,
Nepean Hospital
12:109:10A tale from the Toxicology Techscape.
Impact of commencing a Virtual Toxicology Service.
Dr Iain McNeillPrincess Alexandra Hospital
12:309:302 verapamil overdoses. 2 outcomes. Did ECMO make the difference?
2 cases of verapamil overdose with 2 very different outcomes. Discussion on VA-ECMO and other options. 
Dr Hwee Min Lee
Monash Health
12:509:50A novel presentation of methaemoglobinaemia secondary to an occupational inhaled nitric acid exposure.
This talk outlines the presentation of two patients developing methaemoglobinaemia after an occupational exposure to inhaled nitric acid and hydrofluoric acid.
Dr James Colalillo,Fiona Stanley Hospital
1:1010:10Break
1:5510:55Real world delays in antivenom administration: Patient, snake or hospital factors 
(ASP-33).
Antivenom has been shown to be more effective if given within hours of the bite. However, currently there are delays in the administration of antivenom.
Dr Geoff Isbister,
University of Newcastle
2:1511:15Antivenom Surveillance: An audit of antivenom stock within South Australia.
An audit of antivenom stock within South Australian health services was conducted and results compared with those recommended in the current published snakebite and spider bite guideline. The audit found that despite gross overstocking of antivenom, at considerable cost, up to 25% of health services do not carry enough stock to deliver effective treatment for one or more envenoming instances.
Dr David Stibbs,
Flinders Medical Centre
2:3511:35Stonefish envenoming: Stonefish antivenom administration efficacy for pain and localised tissue damage prevention.
2 Case presentations. Stonefish Antivenom- to be or not to be? When the benefit outweighs the risk. Specific indications and benefits learned in a tropical medicine setting.
Dr Shannon Baso,
Cairns Hospital
2:5511:55A Fish out of Water.
Tetrodotoxin poisoning from puffer fish ingestion.
Dr Alastair Ward,
Royal Adelaide Hospital
3:1512:15A Snaky Dilemma: Management issues in taipan envenoming with delayed presentation.
A 64yo man transferred from Cape York is envenomed by a taipan, but the bite occurred 14 hrs ago. We discuss some of the dilemmas of snake envenoming management in rural Australia.
Dr Mark Little,
Cairns Hospital
3:3512:35Not your grandma's opium.
Case report of prolonged opioid toxidrome with recurrent toxicity related to recreational use of an insufflated novel opioid.
Dr Tim Cook,
Sir Charles Gairdner Hospital
3:5512:55Closing Remarks



Cost

TAPNA Member:  FREE  

Non Member:  In Person: $120  |  Zoom:  $60



To Register



Contact

If you have any questions, please do not hesitate to contact the TAPNA Secretariat

T:  02 4973 6573
Esecretariat@tapna.org.au



An Important Note About Privacy:

Please note that this database is managed as agent for and on behalf of the Toxicology And Poisons Network Australasia Incorporated (ABN 27 768 506 633) (“TAPNA”) by Cattle Dog Consultancy Pty Ltd (ABN 35 611 514 213).  The information you provide when you submit your personal information to us will be collected by Cattle Dog Consultancy Pty Ltd and will be shared with TAPNA, as set in our privacy collection statements and privacy policy.